GK
PFE icon

Graney & King’s Pfizer PFE Stock Holding History

Graney & King’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Buy
1,856
+11
+0.6% +$288 0.02% 164
2026
Q1 		$51.8K Buy
1,845
+10
+0.5% +$266 0.03% 142
2025
Q4 		$45.7K Buy
1,835
+11
+0.6% +$277 0.03% 145
2025
Q3 		$46.5K Buy
1,824
+10
+0.6% +$247 0.03% 141
2025
Q2 		$44K Buy
1,814
+11
+0.6% +$257 0.03% 138
2025
Q1 		$45.7K Buy
1,803
+10
+0.6% +$262 0.03% 128
2024
Q4 		$47.6K Buy
+1,793
New +$48.6K 0.04% 127

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Graney & King's PFE Position: Q2 2026 in Review

Graney & King increased its Pfizer (PFE) stake by 0.6% in Q2 2026, buying an estimated $288 and bringing the position to 1,856 shares worth $44.7K. The position accounts for 0.02% of the portfolio, ranked #164.

Graney & King first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $51.8K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Graney & King held 1,856 shares of Pfizer worth $44.7K as of Q2 2026.
  • Graney & King bought 11 Pfizer shares in Q2 2026, an estimated $288.
  • Pfizer made up 0.02% of Graney & King's portfolio in Q2 2026, its #164 holding.
  • Graney & King first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Graney & King's Pfizer position peaked at $51.8K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.